logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BEAUTYFARM MED (02373) repurchased 40,000 shares for HK$742,600 on September 24.

date
19:22 24/09/2026
avatar
GMT Eight
Beauty Farm Medical and Health (02373) announced that on September 24, 2026, it repurchased 40,000 shares for HK$742,600.
BEAUTYFARM MED (02373) announced that on September 24, 2026, it repurchased 40,000 shares for HK$742,600.
Related Articles
HK Stock
Shenzhen Zhaowei Machinery & Electronics (02692) repurchased 67,800 shares on September 24 for approximately HK$2.6433 million.
HK Stock
EXTREME VISION (06636) plans to inject RMB 138 million in capital increase into Hengqin EXTREME VISION.
HK Stock
LIFETECH SCI(01302): The SureCham Aortic Arch Single-Branch Stent Graft System Enters the Innovative Medical Management Device Special Review Program
Shenzhen Zhaowei Machinery & Electronics (02692) repurchased 67,800 shares on September 24 for approximately HK$2.6433 million.
HK Stock
EXTREME VISION (06636) plans to inject RMB 138 million in capital increase into Hengqin EXTREME VISION.
HK Stock
LIFETECH SCI(01302): The SureCham Aortic Arch Single-Branch Stent Graft System Enters the Innovative Medical Management Device Special Review Program
HK Stock
RECOMMEND
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.